A list of active investigative brain tumor protocols in North America
is presented. The fact that there are 138 protocols (and certainly som
e have been missed) indicates the diversity and intensity of research
into this difficult problem. The geographic diversity of institutions
involved in brain tumor clinical trials also underscores the opportuni
ty available to a large number of clinicians caring for patients with
brain tumors to refer them for participation in such a study.